Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.100
-0.070 (-3.23%)
At close: Apr 28, 2026, 4:00 PM EDT
2.120
+0.020 (0.95%)
Pre-market: Apr 29, 2026, 8:43 AM EDT

Microbot Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Selling, General & Admin
8.735.224.345.775.41
Upgrade
Research & Development
6.016.415.517.515.95
Upgrade
Operating Expenses
14.7411.639.8613.2811.36
Upgrade
Operating Income
-14.74-11.63-9.86-13.28-11.36
Upgrade
Interest & Investment Income
1.290.180.230.120.04
Upgrade
Other Non Operating Income (Expenses)
0.32----
Upgrade
EBT Excluding Unusual Items
-13.14-11.44-9.63-13.16-11.31
Upgrade
Gain (Loss) on Sale of Assets
---0-0.01-
Upgrade
Legal Settlements
---1.11--
Upgrade
Pretax Income
-13.14-11.44-10.74-13.17-11.31
Upgrade
Net Income
-13.14-11.44-10.74-13.17-11.31
Upgrade
Net Income to Common
-13.14-11.44-10.74-13.17-11.31
Upgrade
Shares Outstanding (Basic)
46161077
Upgrade
Shares Outstanding (Diluted)
46161077
Upgrade
Shares Change (YoY)
192.69%53.38%40.49%2.14%-0.14%
Upgrade
EPS (Basic)
-0.29-0.73-1.05-1.81-1.59
Upgrade
EPS (Diluted)
-0.29-0.73-1.05-1.81-1.59
Upgrade
Free Cash Flow
-13.11-8.85-8.57-11.63-9.42
Upgrade
Free Cash Flow Per Share
-0.29-0.57-0.84-1.60-1.33
Upgrade
EBITDA
-14.7-11.53-9.75-13.18-11.28
Upgrade
D&A For EBITDA
0.050.090.110.10.08
Upgrade
EBIT
-14.74-11.63-9.86-13.28-11.36
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.